Microalgae Market Research Report Forecast Till 2030

List of Tables

Market Overview

Microalgae Market is anticipated to register a healthy CAGR of 6.93% during the review period.

The demand for seaweed is expanding across the world from the food and drink industry attributable to the capacity of seaweed to add dietary benefits to food products. For example, seaweed was significantly consumed in Asia nations beforehand; be that as it may, attributable to the spread of the Asian populace in different nations like the US, Canada, and France. Macroalgae are added newly in food products or used as a food ingredient in the readiness of wholesome food products. Additionally, a few seaweed-produced hydrocolloids are used to expand the thickness and strength of food products. It likewise has a few different applications, for example, gel framing and involving it as a water-solvent film. Alginate, carrageenan, and agar are the most used full-scale green growth removes. They are used as settling, gelling, thickening, and emulsifying specialists in various food products, for example, bread kitchen products, frozen yogurts, organic product juices, jams, and numerous others.

Market Segmentation

The Microalgae Market segmentation, based on type, includes Dunaliella, Salina, Chlorella, Spirulina, Haematococcus, Nannochloropsis, and Others. Based on source the market is divided into marine water and fresh water. Marine microalgae are an excellent source of bioactive compounds, including pigments, fatty acids, polysaccharides, and proteins.

Based on form, the Microalgae Market includes dry/powder and liquid. The Microalgae Market segmentation based on application, includes food & beverages, pharmaceuticals, cosmetics and beauty care products, animal feed, biofuel, and others. The Microalgae Market segmentation, based on distribution channels, includes B2B and B2C.

Regional Insights

The North America microalgae market is a developing industry, driven by the rising demand for practical and eco-friendly products in different areas. Microalgae are minuscule plants that are wealthy in supplements and can be used for various applications, including food, creature feed, biofuels, beauty care products, and drugs. The market for microalgae in North America is expected to fill essentially before long, driven by the rising demand for regular products and the developing spotlight on supportable and harmless to the ecosystem rehearses.

Expanding medical services spending, developing geriatric populace, food advancements, evolving Ways of life, and medical discoveries have benefitted demand for superfoods. Expanding mindfulness regarding superfoods as regular, supplement-rich foods containing vitamins and minerals are a portion of the key perspectives forming the prominence of microalgae products in the country.

This Asia-Pacific microalgae market is seeing huge market development due to the abundant production of spirulina in nations like Korea, Indonesia, and China. The broad joining of spirulina in the nutraceutical industry to produce protein-rich dietary supplements has supported the development of the market.

Major Players

The key players in the microalgae market include Cyanotech Corporation, Algenol Biotech, DIC Corporation, Taau Australia, E.I.D Parry Ltd, Fuqing Spirulina Co. Ltd, Cellana Inc, Kent BioEnergy Corporation, and Astareal AB.

Product Code: MRFR/F-B & N/9756-CR

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 14

1.1.1 GLOBAL MICROALGAE MARKET, BY TYPE 16
1.1.2 GLOBAL MICROALGAE MARKET, BY FORM 17
1.1.3 GLOBAL MICROALGAE MARKET, BY SOURCE 18
1.1.4 GLOBAL MICROALGAE MARKET, BY APPLICATION 19
1.1.5 GLOBAL MICROALGAE MARKET, BY DISTRIBUTION CHANNEL 20
1.1.6 GLOBAL MICROALGAE MARKET, BY REGION 21

2 MARKET INTRODUCTION 22

2.1 DEFINITION 22
2.2 SCOPE OF THE STUDY 22
2.3 SCOPE OF THE STUDY 22
2.4 MARKET STRUCTURE 23

3 RESEARCH METHODOLOGY 24

3.1 RESEARCH PROCESS 24
3.2 PRIMARY RESEARCH 25
3.3 SECONDARY RESEARCH 26
3.4 MARKET SIZE ESTIMATION 26
3.5 TOP DOWN & BOTTOM-UP APPROACH 27
3.6 FORECAST MODEL 28
3.7 LIST OF ASSUMPTIONS 29

4 MARKET DYNAMICS 30

4.1 DRIVERS 30
- 4.1.1 INCREASING CONSUMPTION OF PLANT-BASED PRODUCTS AND ADOPTION OF COMMERCIAL SEAWEED AS HYDROCOLLOIDS 30
- 4.1.2 INCREASED APPLICATION AREAS 31
- 4.1.3 DRIVER IMPACT ANALYSIS 32
4.2 RESTRAINTS 32
- 4.2.1 HIGH COST OF SEAWEED CULTIVATION AND STRINGENT REGULATIONS ON MICROALGAE PRODUCTION AND CONSUMPTION OF FOOD 32
- 4.2.2 RESTRAINT IMPACT ANALYSIS 33
4.3 OPPORTUNITIES 33
- 4.3.1 EXPANSION OF AQUACULTURE INDUSTRY AND INCREASING APPLICATION OF SPIRULINA MICROALGAE 33
4.4 CHALLENGES 34

5 MARKET FACTOR ANALYSIS 35

5.1 VALUE/SUPPLY CHAIN ANALYSIS 35
- 5.1.1 RAW MATERIALS 36
- 5.1.2 MANUFACTURING PROCESS 36
- 5.1.3 DISTRIBUTION 36
- 5.1.4 END USER 36
5.2 PORTER'S FIVE FORCES MODEL 37
- 5.2.1 THREAT OF NEW ENTRANTS 38
- 5.2.2 BARGAINING POWER OF SUPPLIERS 38
- 5.2.3 THREAT OF SUBSTITUTES 38
- 5.2.4 BARGAINING POWER OF BUYERS 38
- 5.2.5 INTENSITY OF RIVALRY 39
5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROALGAE MARKET 39
- 5.3.1 IMPACT ON SUPPLY CHAIN 39
- 5.3.2 IMPACT ON PRODUCTION 40
- 5.3.3 IMPACT ON CONSUMER BUYING BEHAVIOR 40
- 5.3.4 IMPACT ON STORE-BASED VS ONLINE SALES 41

6 GLOBAL MICROALGAE MARKET, BY TYPE 42

6.1 OVERVIEW 42
6.2 DUNALIELLA SALINA 43
6.3 CHLORELLA 44
6.4 SPIRULINA 45
6.5 HAEMATOCOCCUS SPP 45
6.6 NANNOCHLOROPSIS 46
6.7 OTHERS 47

7 GLOBAL MICROALGAE MARKET, BY SOURCE 48

7.1 OVERVIEW 48
7.2 MARINE WATER 49
7.3 FRESH WATER 49

8 GLOBAL MICROALGAE MARKET, BY SOURCE FORM 51

8.1 OVERVIEW 51
8.2 DRY/POWDER 52
8.3 LIQUID 52

9 GLOBAL MICROALGAE MARKET, BY APPLICATION 54

9.1 OVERVIEW 54
9.2 FOOD & BEVERAGES 55
9.3 PHARMACEUTICALS 56
9.4 COSMETICS & BEAUTY CARE PRODUCTS 57
9.5 ANIMAL FEED 58
9.6 BIO-FUEL 58
9.7 OTHERS 59

10 GLOBAL MICROALGAE MARKET, BY DISTRIBUTION CHANNEL 61

10.1 OVERVIEW 61
10.2 B2B 62
10.3 B2C 62

11 GLOBAL MICROALGAE, BY REGION 64

11.1 OVERVIEW 64
11.2 NORTH AMERICA 65
- 11.2.1 US 68
- 11.2.2 CANADA 70
- 11.2.3 MEXICO 71
11.3 EUROPE 73
- 11.3.1 GERMANY 76
- 11.3.2 FRANCE 77
- 11.3.3 ITALY 79
- 11.3.4 SPAIN 80
- 11.3.5 UK 82
- 11.3.6 REST OF EUROPE 83
11.4 ASIA-PACIFIC 85
- 11.4.1 CHINA 87
- 11.4.2 JAPAN 89
- 11.4.3 INDIA 90
- 11.4.4 AUSTRALIA & NEW ZEALAND 92
- 11.4.5 REST OF ASIA PACIFIC 93
11.5 REST OF THE WORLD 95
- 11.5.1 SOUTH AMERICA 98
- 11.5.2 MIDDLE EAST 99
- 11.5.3 AFRICA 101

12 COMPETITIVE LANDSCAPE 103

12.1 COMPETITIVE OVERVIEW 103
12.2 MAJOR GROWTH STRATEGY IN THE GLOBAL MICROALGAE MARKET 103
12.3 COMPETITIVE BENCHMARKING 105

13 COMPANY PROFILES 106

13.1 ALGENOL BIOTECH 106
- 13.1.1 COMPANY OVERVIEW 106
- 13.1.2 FINANCIAL OVERVIEW 106
- 13.1.3 PRODUCTS OFFERED 106
- 13.1.4 KEY DEVELOPMENTS 107
- 13.1.5 SWOT ANALYSIS 107
- 13.1.6 KEY STRATEGIES 107
13.2 CELLANA, INC. 109
- 13.2.1 COMPANY OVERVIEW 109
- 13.2.2 FINANCIAL OVERVIEW 109
- 13.2.3 PRODUCTS OFFERED 109
- 13.2.4 KEY DEVELOPMENTS 110
- 13.2.5 SWOT ANALYSIS 110
- 13.2.6 KEY STRATEGIES 110
13.3 CYANOTECH CORPORATION 111
- 13.3.1 COMPANY OVERVIEW 111
- 13.3.2 FINANCIAL OVERVIEW 112
- 13.3.3 PRODUCTS OFFERED 112
- 13.3.4 KEY DEVELOPMENTS 112
- 13.3.5 SWOT ANALYSIS 113
- 13.3.6 KEY STRATEGIES 113
13.4 DIC CORPORATION 114
- 13.4.1 COMPANY OVERVIEW 114
- 13.4.2 FINANCIAL OVERVIEW 115
- 13.4.3 PRODUCTS OFFERED 115
- 13.4.4 KEY DEVELOPMENTS 116
- 13.4.5 SWOT ANALYSIS 116
- 13.4.6 KEY STRATEGIES 117
13.5 EID PARRY. 118
- 13.5.1 COMPANY OVERVIEW 118
- 13.5.2 FINANCIAL OVERVIEW 118
- 13.5.3 PRODUCTS OFFERED 119
- 13.5.4 KEY DEVELOPMENTS 119
- 13.5.5 SWOT ANALYSIS 119
- 13.5.6 KEY STRATEGIES 120
13.6 FUQING KING DNARMSA SPIRULINA CO., LTD. 121
- 13.6.1 COMPANY OVERVIEW 121
- 13.6.2 FINANCIAL OVERVIEW 121
- 13.6.3 PRODUCTS OFFERED 121
- 13.6.4 KEY DEVELOPMENTS 122
13.7 KENT BIOENERGY 123
- 13.7.1 COMPANY OVERVIEW 123
- 13.7.2 FINANCIAL OVERVIEW 123
- 13.7.3 PRODUCTS OFFERED 123
- 13.7.4 KEY DEVELOPMENTS 123
13.8 AUSTRALIAN SPIRULINA 124
- 13.8.1 COMPANY OVERVIEW 124
- 13.8.2 FINANCIAL OVERVIEW 124
- 13.8.3 PRODUCTS OFFERED 124
- 13.8.4 KEY DEVELOPMENTS 124
13.9 ASTAREAL AB. 125
- 13.9.1 COMPANY OVERVIEW 125
- 13.9.2 FINANCIAL OVERVIEW 125
- 13.9.3 PRODUCTS OFFERED 125
- 13.9.4 KEY DEVELOPMENTS 125
- 13.9.5 KEY STRATEGIES 126